SCHEMBL28724712

SCHEMBL28724712

COC(=O)C[C@@H]1COc2ccc(F)cc2O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.56
CA2 P00918 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MTNR1A P48039 1/20 0.49
FFAR1 O14842 3/20 0.48
ALOX5 P09917 3/20 0.48
ALDH1A1 P00352 2/20 0.48
GAA P10253 2/20 0.46
MAPT P10636 1/20 0.46
NR3C2 P08235 1/20 0.46
AIMP2 Q13155 1/20 0.44
RAB9A P51151 1/20 0.43
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HTR1A P08908 1/20 0.43
DRD4 P21917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28723917 1.00 DRD2 (0.56) DRD2CA2CYP1A2CYP3A4CYP2D6
SCHEMBL28723946 0.96 CA2 (0.55) DRD2CA2CYP1A2CYP3A4CYP2D6
SCHEMBL28723925 0.85 CA2 (0.57) DRD2CA2CYP1A2CYP3A4CYP2D6
SCHEMBL28938415 0.85 CA2 (0.57) DRD2CA2CYP1A2CYP3A4CYP2D6
SCHEMBL28724511 0.84 CA2 (0.56) DRD2CA2CYP1A2CYP3A4CYP2D6
SCHEMBL28724507 0.84 CA2 (0.56) DRD2CA2CYP1A2CYP3A4CYP2D6
SCHEMBL9692477 0.83 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10916152 0.83 MTNR1A (0.48) DRD2CA2CYP1A2CYP3A4CYP2D6
SCHEMBL19776284 0.81 DRD2 (0.54) DRD2CA2MTNR1AFFAR1ALOX5
SCHEMBL19776654 0.81 DRD2 (0.54) DRD2CA2MTNR1AFFAR1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689664-B Tricyclic heteroaryl substituted quinoline and azaquinoline compounds as PAR4 inhibitors 百时美施贵宝公司 2022-04-15 CN disclosed